Completed PHASE1 INTERVENTIONAL NCT00091325

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Phase I Drug Interaction Clinical Study of Polyphenon E

Sponsor: National Cancer Institute (NCI)

Conditions Unspecified Adult Solid Tumor, Protocol Specific

Interventions defined green tea catechin extract

Updated 5 times since 2017 Last updated: Jan 15, 2010 Started: Oct 31, 2004 Primary completion: Mar 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00091325, this PHASE1 trial focuses on Unspecified Adult Solid Tumor, Protocol Specific and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 5 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Arizona

Data source: University of Arizona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tucson, United States